Prevalence Of Oral HPV Was Found To Be Low Among Population Of Young, Urban MSM In Canada Following Introduction Of Publicly-Funded HPV Vaccination Programs, Study Shows

August 29, 2024

Infectious Disease Advisor (8/28, Basilio) reports, “The prevalence of oral human papillomavirus (HPV) was found to be low among a population of young, urban men who have sex with men (MSM) in Canada following the introduction of publicly-funded HPV vaccination programs, according to study results.” Investigators also observed “that vaccinated patients were at reduced risk for oral 4-valent (odds ratio [OR], 0.3; 95% CI, 0.0-2.6) and 9-valent (OR, 0.4; 95% CI, 0.1-2.1) HPV infections, corresponding to vaccine effectiveness estimates of 70% (95% CI, -161 to 96) and 57% (95% CI, -110 to 91), respectively.” The findings were published in The Journal of Infectious Diseases.